Summit co-CEO option exercise ‘quite bullish,’ says Cantor Fitzgerald

3 months ago 26

TipRanks

Fri, Apr 11, 2025, 9:15 AM 1 min read

In This Article:

Cantor Fitzgerald views Bob Duggan’s, Summit Therapeutics (SMMT) co-CEO and Chairman, banal enactment workout “quite unusual” and “quite bullish” for the shares. Duggan’ exercised warrants to acquisition 4M shares of Summit astatine $1.58 astir 4 years earlier their expiration, the expert tells investors successful a probe note. Cantor has an Overweight standing connected Summit Therapeutics. The banal successful midday trading is up 9%, oregon $1.66, to $19.89.

Discover outperforming stocks and put smarter with Top Smart Score Stocks.
Filter, analyze, and streamline your hunt for concern opportunities utilizing Tipranks' Stock Screener.

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See the apical stocks recommended by analysts >>

Read More connected SMMT:

Disclaimer & DisclosureReport an Issue

Expert says Summit’s HARMONi-2 survey could bushed expectations, says Truist
Optimistic Buy Rating for Summit Therapeutics Driven by Promising HARMONi-2 Trial and Favorable Regulatory Pathway successful China
Promising Potential of Ivonescimab successful Oncology: A Buy Recommendation for Summit Therapeutics
Moleculin, CNS, Global-e, Tenet, Summit: Trending by Analysts
Summit Therapeutics upgraded to Buy from Neutral astatine Citi

Read Entire Article